Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate

Photodiagnosis and Photodynamic Therapy

Volumn 7, Issue 2, 2010, Pages 106-114

  Xiao, Zhengwen ^a   Owen, Richard J ^a   Liu, Weiyang ^a   Tulip, John ^a   Brown, Kevin ^b   Woo, Thomas ^b   Moore, Ronald B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Quest PharmaTech Inc   (Canada)

Author keywords

Intra artery injection; Photodynamic therapy; Prostate; Switched light delivery

Indexed keywords

DIMETHYL SULFOXIDE; LIPOSOME; PHOTOSENSITIZING AGENT; SL 052; UNCLASSIFIED DRUG; PERYLENE; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOG; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; PENIS ARTERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; URINE RETENTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS;

ANIMALS; DOGS; INFUSIONS, INTRA-ARTERIAL; LIPOSOMES; MALE; MOLECULAR STRUCTURE; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATIC NEOPLASMS; QUINOXALINES;

ANIMALIA; CANIS FAMILIARIS;

EID: 77952542706     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2010.03.003     Document Type: Article

References (18)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Michaelson M.D., Cotter S.E., Gargollo P.C., Zietman A.L., Dahl D.M., and Smith M.R. Management of complications of prostate cancer treatment. CA Cancer J Clin 58 (2008) 196-213
3. Xiao Z., Dickey D., Owen R.J., Tulip J., and Moore R.B. Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery. J Urol 178 (2007) 308-313
4. Nathan T.R., Whitelaw B.E., Chang S.C., et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 168 (2002) 1427-1432
5. Trachtenberg J., Weersink R.A., Davidson S.R.H., et al. Vascular-targeted photodynamic therapy (padoporfin WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int 102 (2008) 556-562
6. Moore R.B., Xiao Z., Owen R.J., et al. Photodynamic therapy of the canine prostate: intra-arterial drug delivery. Cardiovasc Intervent Radiol 31 (2008) 164-176
7. Xiao Z., Halls S., Dickey D., Tulip J., and Moore R.B. Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of Dunning prostate carcinomas. Clin Cancer Res 13 (2007) 7496-7505
8. Paul B.T., Babu M.S., Santhoshkumar T.R., et al. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents. J Photochem Photobiol B Biol 94 (2009) 38-44
9. Allison R.R., Mota H.C., and Sibata C.H. Clinical PD/PDT in North America: an historical review. Photodiagn Photodyn Ther 1 (2004) 263-277
10. Selman S.H., Albrecht D., Keck R.W., Brennan P., and Kondo S. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J Urol (2001) 1795-1801
11. Chang S., Buonaccorsi G., MacRobert A., and Bown S.G. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra (hydroxyphenyl) chlorine. Int J Cancer 67 (1996) 555-562
12. Chen B., Pogue B.W., and Hasan T. Liposomal delivery of photosensitizing agents. Expert Opin Drug Deliv 2 (2005) 477-487
13. Hogg J.C., Ho C., Brumwell M.L., et al. Erythrocyte and polymorphonuclear cell transit time and concentration in human pulmonary capillaries. J Appl Physiol 4 (1994) 1795-1800
14. Liu D., Mori A., and Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta 1104 (1992) 95-101
15. Liu D., Mori A., and Huang L. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. Biochim Biophys Acta 1066 (1991) 159-165
16. Rastinehad A.R., Caplin D.M., Ost M.C., et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 71 2 (2008) 181-184
17. Park Y.H., Lee J.H., and Kim H.H. Severe bleeding after laparascopic radical prostatectomy: successful management with transarterial embolization. J Endourol 22 12 (2008) 2687-2689
18. Carnevale F.C., Antunes A.A., and da Motta Leal Filho J.M. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33 2 (2010) 355-361